Uncategorized

Dr. Stephen Palmer Joins the Celmatix Executive Team to Lead the Company’s Drug Discovery and Development Efforts in Ovarian Health as Chief Scientific Officer

Women’s Health Biotech Celmatix focused uniquely on ovarian biology has announced the appointment of Dr. Stephen Palmer as Chief Scientific Officer. Dr. Palmer had previously joined the company’s Scientific Advisory Board earlier this year, on the heels of rapid progress with Celmatix’s lead AMHR2 agonist program and the out-licensing of PCOS targets from its multi-omics ovarian health platform. Dr. Palmer is a…

Madrid-based IVF Startup Overture Life Raises a $15M Series B

Overture Life, the IVF process automation startup has announced a $15M in a Series B round bringing its fundraising total to $37M. Octopus Ventures led the Series B round. Existing investors such as Khosla Ventures, Felicis Ventures, and Marc Benioff also participated in the round. Google Ventures, also participant in the round, made its first Spain-based investment. Overture Life wants to democratize…

Always Participates in a U.S. Congressional Event and Releases New Global Data to Break Period Stigma

In honor of Menstrual Hygiene Day on May 28, Procter & Gamble’s leading menstrual care brand Always is launching a campaign to champion young people’s confidence through period education and other efforts aimed at tackling period stigma and improving access to period products. Tomorrow, Always will participate in the Ending Period Poverty for Women and Girls event sponsored by the Women’s Congressional Policy…

CBD Therapeutics Startup Prima Raises a $9.2M Seed Plus Round

Prima, a purpose-driven brand focused on efficacy-driven and science-backed plant therapeutics and cannabinoids, today announced the close of a $9.2M Seed Plus financing led by leading institutional venture firms Greycroft, H Ventures, Defy, and Lerer Hippeau, with participation from Adam Zeplain (mark vc), Global Founders Capital, Emerald Health, One Gun, and Purple Arch Ventures.  The funding will support sustainable growth and power upcoming retail expansion, remedy-focused clinical research, portfolio refinements and education initiatives…

Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health

Aspira Women’s Health, a bioanalytical-based women’s health company focused on gynecologic disease and The Feinstein Institutes for Medical Research, the science arm of Northwell Health, the largest private Healthcare Provider in New York State, today announced the start of a prospective Clinical Study for Ovarian Cancer Risk Detection. Northwell Health treats over 2 million patients annually and employs over 16,000 credentialled physicians. The…

Twentyeight Health Announces U.S. Expansion to Increase Birth Control Access for Underserved Communities

Twentyeight Health, a telehealth company increasing access to sexual and reproductive healthcare for women from underserved communities, today announced that it is continuing its national expansion with launches across seven states — Alabama, Colorado, Georgia, Kentucky, Nebraska, Tennessee, and Virginia. Twentyeight Health is now available to women across 20 states, serving over 70% of U.S. women of reproductive age.  “Telehealth had a…

LiquidGoldConcept Receives an NIH Grant for Further Commercialization of its Lactation Support Training Technology

U.S. based femtech startup LiquidGoldConcept announced it has been awarded an additional $55,000 in National Institutes of Health (NIH) funding in support of its Lactation Simulation Models (LSM) and Newborn Oral Assessment and Latch Simulators (NORALSim). The new grant is in addition to $250,000 in NIH support the company received in July of 2020 for its breastfeeding training technology. The $55,000 grant is through the National Centers for Clinical and Translational Science (NCATS), a…